Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-eell leukemia cells by a paracrine mechanism

Blood

Volumn 111, Issue 10, 2008, Pages 5163-5172

  Chen, Jing ^a   Petrus, Mike ^a   Bryant, Bonita R ^a   Nguyen, Vinh Phuc ^a   Stamer, Mindy ^a   Goldman, Carolyn K ^a   Bamford, Richard ^b   Morris, John C ^a   Janik, John E ^a   Waldmann, Thomas A ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Transponics   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 9; INTERLEUKIN 9 RECEPTOR; PROTEIN SUBUNIT; TAX PROTEIN;

ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; EX VIVO STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PARACRINE SIGNALING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PURIFICATION; T CELL LEUKEMIA; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MONOCYTE; PATHOLOGY; PHYSIOLOGY; T CELL LEUKEMIA LYMPHOMA; T LYMPHOCYTE;

CELL PROLIFERATION; GENE EXPRESSION REGULATION, LEUKEMIC; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERLEUKIN-9; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MONOCYTES; PARACRINE COMMUNICATION; RECEPTORS, INTERLEUKIN-9; T-LYMPHOCYTES;

EID: 46749096836     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-09-113654     Document Type: Article

References (42)

1. Takatsuki K, Uchiyama T. Sagawa K, Yodoi J. Adult T-cell leukemia in Japan. Excerpta Med. 1977;73-77.
2. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50: 481-492.
3. Poiesz BJ; Ruscetti FW; Reitz MS, Kalyanaraman VS. Gallo RC. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukaemia. Nature. 1981 ;294: 268-271.
4. Yoshida M, Miyoshi L Hinuma M. Isolation and characterization of retrovirus (ATLV) from cell lines of adult T cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982;79: 2031-2036.
5. Peloponese JM, Yeung ML, Jeang KT. Modulation of nuclear factor-kappaB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation. Immunol Res. 2006;34:1-12.
6. Wano Y, Hattori T, Matsuoka M, et al. Interleukin 1 gene expression in adult T-cell leukemia. J Clin Invest. 1987;80:911-916.
7. Wano Y, Feinberg M, Hosking JB, Bogerd H, Greene WC. Stable expression of the Tax gene of type I human T-cell leukemia virus in human T-cells activates specific cellular genes involved in growth. Proc Natl Acad Sci U S A. 1988:85:9733- 9737.
8. Muraoka O. Kaisho T, Tanabe M, Hirano T. Transcriptional activation of the interleukin-6 gene by HTLV-I p40tax through an NF-kappa B-like binding site. Immunol Lett. 1993:37:159-165.
9. Azimi N, Brown K, Bamford RN, Tagaya Y, Siebenlist U, Waldmann TA. Human T-cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site. Proc Natl Acad Sci U S A. 1998;95: 2452-2457.
10. Chung HK. Young HA, Goon PK, et al. Activation of interleukin-13 expression in T cells from HTLV- l-infected individuals and in chronically infected cell lines. Blood. 2003;102:4130-4136.
11. Himes SR, Goles LS, Katsikeros R, Lang RK, Shannon MR HTLV-I tax activation of the GM- CSF and G-CSF promoters requires the interaction of NF-κB with other transcription factor families. Oncogene. 1993; 3189-3197.
12. Yamada Y, Sugawara K, HataT, et al. Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2- dependent adult T-cell leukemia (ATL) cell lines: expression of IL-15 receptor (3 on ATL cells. Blood. 1998;91:4265-4272.
13. Mariner JM, Lantz V Waldmann TA, Azimi N. Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF- kappa B site. J Immunol. 2001 ;166:2602-2609.
14. Renauld JC. New insights into the role of cytokines in asthma. J Clin Pathol. 2001 ;54:577-589.
15. Soussi-Gounni A, Kontolemos M, Hamid Q. Role of IL-9 in the pathophysiology of allergic diseases. J Allergy Clin Immunol. 2001 ;107:575- 582.
16. Demoulin JB, Renauld JC. Interleukin 9 and its receptor: an overview of structure and function. Int Rev Immunol. 1998;16:345-364.
17. Renauld JC. Goethals A. Houssiau F, et al. Human P40/IL-9. Expression in activated CD4+ T cells, genomic organization, and comparison with the mouse gene. J Immunol. 1990; 144:4235- 4241.
18. Renauld JC. Druez C, Kermouni A, et al. Expression cloning of the murine and human interleukin 9 receptor cDNAs. Proc Natl Acad Sci U S A. 1992;89:5690-5694.
19. Renauld JG, Kermouni A, VinkA, Louahed J, Van Snick J. lnterleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis. J Leukoc Biol. 1995;57:353-360.
20. Kelleher K, Bean K, Clark SC, et al. Human inter- leukin-9: genomic sequence, chromosomal location, and sequences essential for its expression in human T-cell leukemia virus (HTLV)-l-trans- formed human T cells. Blood. 1991 ;77:1436- 1441.
21. Matsushita K, Arima N, Ohtsubo H, et al. Frequent expression of interleukin-9 mRNA and infrequent involvement of interleukin-9 in proliferation of primary adult T-cell leukemia cells and HTLV-I infected T-cell lines. Leuk Res. 1997;21: 211-216.
22. Baba H, Yamada Y, Mori N, et al. Multiple gamma c-receptor expression in adult T-cell leukemia. Eur J Haematol. 2002;68:362-369.
23. Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia. 1994;8:652-658.
24. Kan no T. Brown K. Franzoso G, Siebenlist U. Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-kappa B. Mol Cell Biol. 1994;14:6443-6451.
25. Brown K, Park S, Kanno T, Franzoso G, Siebenlist U. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor. I kappa B- alpha. Proc Natl Acad Sci U S A. 1993;90:2532- 2536.
26. Brown K, Gerstberger S, Garlson L, Franzoso G, Siebenlist U. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science. 1995;267:1485-1488.
27. Lenardo MJ, Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 1989;58:227-229.
28. Fried M, Crothers DM. Equilibria and kinetics of lac repressor-operator interactions by polyacryl- amide gel electrophoresis. Nucleic Acids Res. 1981;9:6505-6525.
29. Lyons B, Doherty K. Flow cytometric analysis of cell division by dye dilution. Current Protocols in Cytometry. 2004;Unit 9.11.
30. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity. 2000;13:199-212.
31. National Center for Biotechnology Information. Gene Expression Omnibus series accession number GSE10789. http://www.ncbi.nlm.nih.gov/ geo/. Accessed March 13, 2008.
32. Ohtani K, Nakamura M, Saito S, Nagata K, Sugamura K, Hinuma Y. Electroporation: application to human lymphoid cell lines for stable introduction of a transactivator gene of human T-cell leukemia virus type I. Nucleic Acids Res. 1989:17: 1589-1604.
33. Tamiya S, Matsuoka M, Etoh K, et al. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood. 1996;88: 3065-3073.
34. Kubota S, Siomi H, Hatanaka M, Pomerantz RJ. Cis/trans-activation of the interleukin-9 receptor gene in an HTLV-l-transformed human lymphocytic cell. Oncogene. 1996;12:1441 -1447.
35. Elovaara I, Utz U, Smith S, Jacobson S. Limited T cell receptor usage by HTLV-I tax-specific, HLA class I restricted cytotoxic T lymphocytes from patients with HTLV-I associated neurological disease. J Neuroimmunol. 1995;63:47-53.
36. Azimi N, Nagai M, Jacobson S, Waldmann TA. IL-15 plays a major role in the persistence of Tax- specific CDS cells in HAM/TSP patients. Proc Natl Acad Sci U S A. 2001 ;98:14559-14564.
37. Tendler CL, Greenberg SJ, Blattner WA, et al. Trans activation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus typre l-associated myelopathy: pathogenic implications and a rational for immunotherapy. Proc Natl Acad Sci U S A. 1990;87: 5218-5222.
38. Fung M, Ghu YL, Fink JL Wallace A, McGuire KL. IL-2- and STAT5-regulated cytokine expression in cells expressing the Tax protein of HTLV-I. Oncogene. 2005;24:4624-4633.
39. Makino M, Azuma M, Wakamatsu SI, et al. Marked suppression of T cells by a benzothiophene derivative in patients with human T-lymphotropic virus type l-associated myelopathy/tropical spastic paraparesis. Clin Diagn Lab Immunol. 1999;6:316-322.
40. Makino M, Shimokubo S, Wakamatsu SI, Izumo S, Baba M. The role of human T-lymphotropic virus type 1 (HTLV-l)-infected dendritic cells in the development of HTLV-l-associated myelopathy/ tropical spastic paraparesis. J Virol. 1999;73: 4575-4581.
41. Lunardi-lskandar Y. Gessain A, Lam VH. Gallo RC. Abnormal in vitro proliferation and differentiation of T cell colony-forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-l)-associated myeloencepha- lopathy and healthy HTLV-I carriers. J Exp Med. 1993;177:741-750.
42. Prince HE, York J, Golding J, Owen SM, Lal RB. Spontaneous lymphocyte proliferation in human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infection: T-cell subset response and their relationships to the presence of provirus and viral antigen production. Clin Diagn Lab Immunol. 1994:1:273-282.